Long-term survival of stage T4N0-1 and single station IIIA-N2 NSCLC patients treated with definitive chemo-radiotherapy using individualised isotoxic accelerated radiotherapy (INDAR)

Bart Reymen, Angela van Baardwijk, Rinus Wanders, Jacques Borger, Anne-Marie C. Dingemans, Gerben Bootsma, Cordula Pitz, Ragnar Lunde, Wiel Geraedts, Philippe Lambin, Dirk De Ruysscher

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)482-487
JournalRadiotherapy and Oncology
Volume110
Issue number3
DOIs
Publication statusPublished - Mar 2014

Keywords

  • Non-small cell lung cancer
  • Radiotherapy
  • Chemotherapy
  • Combined modality treatment
  • T4

Cite this